January 2026

SIGN UP FOR OUR NEWSLETTER

A SPOTLIGHT ON SIOLTA THERAPEUTICS


How Siolta Therapeutics is Preventing Allergic Disease in Infants


When asked about advice for other founders, Nikole Kimes offers wisdom that clearly comes from experience: "Listen to your gut. Many of us are not following a map. We are creating one. We are pushing into territory where precedent is scarce and certainty is rare. Trust your instincts. Your perspective is not a weakness; it is your edge."  


This philosophy has defined Siolta Therapeutics from the start. When Nikole co-founded the company, the vision was to focus on preventing allergic diseases in infants before symptoms ever appear — not to manage them or treat them after diagnosis, but to stop them from developing in the first place.  


In a recent conversation with CEO Nikole Kimes and CSO Ricardo Valladares, they shared the story behind Siolta's approach to allergic disease prevention.




READ THE FULL STORY  ►

THE LATEST

SEE WHAT’S HAPPENING

MEET OUR NEWEST RESIDENTS

While AI and autonomous systems demand ever-increasing computing power, chip manufacturers are facing a scaling crisis: the copper wires connecting processors and memory must become 10x thinner to sustain data speeds, a feat current manufacturing methods cannot achieve cost-effectively. NanoPattern Technologies, Inc. has developed a proprietary chemical compound that enables the fabrication of 20x thinner wires while remaining cost-competitive.


We are thrilled to welcome CEO and Cofounder Yu Kambe, CTO Danielle Chamberlin, and VP of Product Development Alice Liu to our 1030 Brittan community in San Carlos!


LEARN MORE  ►

Published On: January 6th, 2026Categories: Newsletters 2026
Feel free to share!